MedlineFRA:L10 +5.16%14 FCF Yield % is 3.13 as of Jun. 28, 2026, which is 8% below its 10-year median of 3.42. GuruFocus rates FRA:L10 with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Medline ranks better than 70.64% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Medline's Trailing 12-Month Free Cash Flow is €882 Mil, and Market Cap is €28,893 Mil. Therefore, Medline's FCF Yield % for today is 3.13%.
The historical rank and industry rank for Medline's FCF Yield % or its related term are showing as below:
FRA:L10'
s FCF Yield % Range Over the Past 10 Years
Min: 1.5 Med: 3.42 Max: 3.94
Current: 3.13
During the past 4 years, the highest FCF Yield % of Medline was 3.94%. The lowest was 1.50%. And the median was 3.42%.
FRA:L10's FCF Yield % is ranked better than 70.64% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs FRA:L10: 3.13
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medline FCF Yield % Related Terms
Medline FCF Yield % Historical Data
* Premium members only.
The historical data trend for Medline's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Medline's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medline FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medline's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medline's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medline (FRA:L10) has a FCF Yield % of 3.13 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medline and its competitors. This is near median its historical median of 3.42. Over the past decade, Medline's FCF Yield % has ranged from 1.50 to 3.94. According to the industry distribution chart, Medline ranks #251 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 29.4%.
Is Medline's FCF Yield % too high?
Medline's current FCF Yield % of 3.13 is near median its 10-year median of 3.42. Over the past 10 years, this metric has ranged from a low of 1.50 to a high of 3.94. Based on the distribution chart, Medline ranks #251 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medline has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Medline's FCF Yield % compare to RMD and WST?
According to the Medical Devices & Instruments industry distribution chart, Medline ranks #251 out of 855 companies for FCF Yield %. This puts Medline in the upper half of its industry. Historically, Medline's own FCF Yield % has ranged from 1.50 to 3.94 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medline and its competitors. Medline's current FCF Yield % is 3.13, which is near median its own 10-year median of 3.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (FRA:L10) has a current FCF Yield % of 3.13. The current FCF Yield % is 3.13, which is near median its 10-year median of 3.42. Medline's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medline (FRA:L10), the current FCF Yield % is 3.13 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
14GF Score
Get the complete analysis for FRA:L10
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L10 has been successfully added to your 
